A detailed history of Neuberger Berman Group LLC transactions in Glaukos Corp stock. As of the latest transaction made, Neuberger Berman Group LLC holds 58,207 shares of GKOS stock, worth $8.78 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
58,207
Previous 47,077 23.64%
Holding current value
$8.78 Million
Previous $5.57 Million 36.12%
% of portfolio
0.01%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$113.62 - $135.39 $1.26 Million - $1.51 Million
11,130 Added 23.64%
58,207 $7.58 Million
Q2 2024

Nov 14, 2024

SELL
$89.48 - $118.35 $604,437 - $799,454
-6,755 Reduced 12.55%
47,077 $5.57 Million
Q2 2024

Aug 13, 2024

SELL
$89.48 - $118.35 $604,437 - $799,454
-6,755 Reduced 12.55%
47,077 $5.57 Million
Q1 2024

Nov 14, 2024

SELL
$76.4 - $96.33 $411,490 - $518,833
-5,386 Reduced 9.1%
53,832 $5.08 Million
Q1 2024

May 13, 2024

BUY
$76.4 - $96.33 $4.11 Million - $5.19 Million
53,832 New
53,832 $5.08 Million
Q4 2023

Nov 14, 2024

BUY
$59.53 - $85.11 $722,753 - $1.03 Million
12,141 Added 25.79%
59,218 $4.71 Million
Q4 2023

Feb 09, 2024

BUY
$59.53 - $85.11 $801,809 - $1.15 Million
13,469 Added 29.44%
59,218 $4.71 Million
Q3 2023

Nov 14, 2023

BUY
$69.23 - $79.09 $22,984 - $26,257
332 Added 0.73%
45,749 $3.44 Million
Q2 2023

Aug 11, 2023

BUY
$45.44 - $71.21 $2.06 Million - $3.23 Million
45,417 New
45,417 $3.23 Million
Q4 2018

Feb 12, 2019

SELL
$52.18 - $67.93 $834,880 - $1.09 Million
-16,000 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$38.13 - $68.37 $610,080 - $1.09 Million
16,000 New
16,000 $1.04 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.18B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.